Applications of Artificial Intelligence in Clinical Validation, Device Approval, and Insurance Coverage

Abstract

Different areas of medicine will probably be impacted by artificial intelligence (AI). Using algorithms of AI for diagnosis and prediction, this paper tries to clarify the underlying ideas guiding device approval, clinical validation and decisions related to insurance coverage. The sensitivity, dice similarity coefficient, specificity, and operating characteristic curves, conventional or free-response receiver are frequently used to assess the discrimination accuracy of AI algorithms. It is important to evaluate calibration accuracy, particularly for algorithms that give users probability. Due to the restricted generalizability of present AI algorithms to practice at real world level. Diagnostic case-control or diagnostic cohort designs may be used in external testing. The validity(clinical) and accuracy of AI are tested in the latter study using samples that represent the target patients in actual clinical circumstances, whereas a detailed case-control diagnostic study assesses the validity on technical ground and how accurate AI is studied. Randomized clinical trials are the optimal method for checking the clinical utility of AI, which is the examination of AI's effect on patient outcomes. The technical validity/accuracy of a device is normally verified before it is approved, therefore this does not necessarily mean that for patient care the device is suitable or that patient outcomes are improved. It also cannot definitively answer the problem of AI's restricted generalizability. It is the responsibility of the professionals practicing in the field of medicine to decide if AI algorithms approval are useful for actual patient related medical care after the device has received approval. Insurance coverage determinations often demand a clinical utility demonstration showing how AI is used has resulted in better patient health improvement outcomes.